Viridian Therapeutics Inc Earnings

The next earnings date for Viridian Therapeutics Inc is November 18, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Viridian Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
11/18/2025$-1

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Viridian Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/06/2025---$-10.00%
05/06/2025Before Market$-0.8721.00%
02/25/2025Before Market$-0.8122.43%
11/11/2024Before Market$-1.15-8.92%
08/08/2024Before Market$-1.02-14.61%
05/08/2024Before Market$-0.7928.18%
02/27/2024After Market$-1.35-35.00%
11/13/2023After Market$-1.0914.17%
08/08/2023After Market$-1.271.55%
05/09/2023After Market$-1.61-57.84%
03/08/2023Before Market$-1.13-54.79%
11/14/2022Before Market$-0.8615.69%
08/15/2022Before Market$-1.06-17.78%
05/12/2022After Market$-0.989.26%
03/10/2022After Market$-1.32-46.67%
11/04/2021After Market$-1.2514.97%
08/11/2021Before Market$-2.21-45.39%
05/06/2021After Market$-2.91-282.89%
03/25/2021After Market$-5.31-770.49%
11/10/2020After Market$-1.5024.62%
08/05/2020After Market$-1.8027.13%
05/07/2020After Market$-2.706.25%
03/11/2020After Market$-4.65-23.02%
11/07/2019After Market$-5.40-21.62%
08/07/2019After Market$-4.3522.18%
05/08/2019After Market$-5.70-10.47%
03/13/2019After Market$-4.95-7.14%
11/07/2018After Market$-4.358.61%
08/07/2018After Market$-4.350.00%
05/09/2018After Market$-2.7026.23%
03/14/2018After Market$-4.358.61%
11/08/2017After Market$-4.0531.36%
08/11/2017After Market$-5.1027.66%
05/10/2017After Market$-9-150.00%
03/24/2017After Market$-3.450.00%
10/26/2016After Market$-3.45---
08/15/2016After Market$-51.75-24.34%
05/16/2016Before Market$-58.507.14%
03/16/2016After Market$-6322.22%
11/12/2015After Market$-87.75-5.41%
08/12/2015After Market$-74.2515.38%
05/14/2015After Market$-101.25-25.00%
03/30/2015Before Market$-387-341.03%
11/14/2014Before Market$-96.75-760.00%
08/08/2014After Market$-254.91---

More About Viridian Therapeutics Inc

Country
USA
Full Time Employees
143

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.

Viridian Therapeutics Inc Earnings” Can Refer to the Viridian Therapeutics Inc Earnings Date

Some people say “Viridian Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Viridian Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Viridian Therapeutics Inc Stock on the Earnings Date

If you own Viridian Therapeutics Inc stock (VRDN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Viridian Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Viridian Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Viridian Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Viridian Therapeutics Inc earnings or anything else related to the stock market.